Bioniche Life Sciences Inc.
Registration:
18
of
30
(2012-01-11
to
2012-09-14)
Grant, Contribution or Other Financial Benefit
- Business Development Bank of Canada relating to debt financing for Pointe-Claire facilities to apply to future expansion of manufacturing capacity.
- Industrial Technologies Office (formerly known as Technology Partnerships Canada Program) relating to an existing funding agreement regarding the development and commercialization of Mycobacterial Cell Wall Technologies.
- Industrial Technologies Office (formerly known as Technology Partnerships Canada Program) relating to an existing funding agreement regarding the development and commercialization of an E. coli vaccine.
- Urocidin plant expansion project relating to the future expansion of the manufacturing capacity of the current Pointe-Claire facilities.
Policies or Program
- Support creation of National E. coli vaccination program for Canadian cattle sponsored by the government.